Procedure
Combined Therapy Group
Total Trials
2
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph not_applicable
2
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
2
all time
Status Distribution
Active(1)
Other(1)
Detailed Status
unknown1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
2
Active
0
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
unknown150%
not_yet_recruiting150%
Recent Activity
0 active trials
Showing 2 of 2
not_yet_recruitingnot_applicable
Neuromodulation-Induced Cortical Prehabilitation in High Grade Glioma Near the Motor Pathway: Cortical Plasticity Assessed by Navigated Transcranial Magnetic Stimulation (nTMS)
NCT07471100
unknownnot_applicable
Outcomes of Vitrectomy Combined With Subtenon Triamcinolone Injection for the Idiopathic Epiretinal Membrane
NCT01630876
Clinical Trials (2)
Showing 2 of 2 trials
NCT07471100Not Applicable
Neuromodulation-Induced Cortical Prehabilitation in High Grade Glioma Near the Motor Pathway: Cortical Plasticity Assessed by Navigated Transcranial Magnetic Stimulation (nTMS)
NCT01630876Not Applicable
Outcomes of Vitrectomy Combined With Subtenon Triamcinolone Injection for the Idiopathic Epiretinal Membrane
All 2 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 2